| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 92,373 | 101,500 | ||
| Accounts receivable, net of allowance for credit losses of 224 and 689 at september 30, 2025 and december 31, 2024, respectively | 9,744 | 9,614 | ||
| Inventory, net | 7,984 | 6,214 | ||
| Prepaid expenses and other current assets | 3,494 | 2,103 | ||
| Total current assets | 113,595 | 119,431 | ||
| Property and equipment, gross | 3,884 | - | ||
| Less accumulated depreciation | 2,339 | - | ||
| Property and equipment, net | 1,545 | 1,460 | ||
| Operating lease right-of-use assets | 568 | 694 | ||
| Other noncurrent assets | 548 | 386 | ||
| Total assets | 116,256 | 121,971 | ||
| Accounts payable | 1,742 | 2,076 | ||
| Accrued compensation | 6,192 | 5,227 | ||
| Accrued and other current liabilities | 3,897 | 4,633 | ||
| Total current liabilities | 11,831 | 11,936 | ||
| Long-term debt, net | 40,069 | 39,821 | ||
| Other noncurrent liabilities | 66 | 202 | ||
| Total liabilities | 51,966 | 51,959 | ||
| Common stock, par value 0.001 per share 200,000,000 shares authorized 52,474,227 and 50,937,999 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 52 | 52 | ||
| Additional paid-in-capital | 444,799 | 442,352 | ||
| Accumulated deficit | -380,561 | -372,392 | ||
| Total stockholders' equity | 64,290 | 70,012 | ||
| Total liabilities and stockholders' equity | 116,256 | 121,971 | ||
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)